Plum Benefits: ₹193 Crore Funding Se Healthtech Banne Ki Taiyari, Valuation $126M Ke Paar!

STARTUPSVC
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Plum Benefits: ₹193 Crore Funding Se Healthtech Banne Ki Taiyari, Valuation $126M Ke Paar!
Overview

Yaar, Plum Benefits ne toh kamaal hi kar diya! Employee health platform ne ₹193 Crore ($20.6 million USD) ki Series B funding uthai hai, jismein Peak XV Partners ne lead kiya. Is deal se company ki valuation lagbhag double hokar ₹11.81 billion ($125.9 million USD) ho gayi hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Toh ab yeh paisa jayega kahaan? Asal mein, Plum ab sirf insurance broking ke business se aage nikal kar ek full-fledged healthtech platform banna chahta hai. Unka goal hai ki future mein revenue ka 40-45% direct healthcare services se aaye, kyunki abhi yeh figure lagbhag 80% insurance commissions par depend karta hai. Yeh shift unke FY24 ke strong results ke baad ho raha hai, jismein operating revenue 2.5X badhkar ₹41.3 crore ho gaya aur losses 54% ghat kar ₹25.5 crore reh gaye. Plus, woh EBITDA aur cash flow mein bhi profitable hain.

Is funding ka istemal technology ko enhance karne, AI-powered claims processing ko behtar banane aur preventive care, mental wellness, telehealth jaise naye services mein expansion ke liye hoga. India ka corporate wellness market jo lagbhag ₹20,000 crore ka hai, usmein yeh move Plum ko ek naya position dega.

Market mein jab VCs thode cautious hain, tab bhi Peak XV Partners, Tanglin Venture Partners aur GMO Venture Partners jaise investors ne is round mein paisa lagaya hai. Yeh unke clear profit path aur strategy par bharosa dikhata hai. Halanki, challenges bhi kam nahi hain. Healthcare expansion ko execute karna, competition ko face karna aur RBI, CCPA jaise regulators ke naye rules ko navigate karna yeh sab mushkil hoga. Naye healthcare services mein profitability dikhana bhi ek bada test hoga.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.